WALVAX BIOTECHNOLO financial statements, including revenue, expenses, profit, and loss

The total revenue of 300142 for the last quarter is 703.60 M CNY, and it's 15.07% lower compared to the previous quarter. The net income of Q3 24 is 85.80 M CNY.